ChatGPT and Clinical Training: Perception, Concerns, and Practice of Pharm-D Students
Open accessAbstract
Background: The emergence of Chat-Generative Pre-trained Transformer (ChatGPT) by OpenAI has revolutionized AI technology, demonstrating significant potential in healthcare and pharmaceutical education, yet its real-world applicability in clinical training warrants further investigation. Methods: A cross-sectional study was conducted between April and May 2023 to assess PharmD students' perceptions, concerns, and experiences regarding the integration of ChatGPT into clinical pharmacy education. The study utilized a convenient sampling method through online platforms and involved a questionnaire with sections on demographics, perceived benefits, concerns, and experience with ChatGPT. Statistical analysis was performed using SPSS, including descriptive and inferential analyses. Results: The findings of the study involving 211 PharmD students revealed that the majority of participants were male (77.3%), and had prior experience with artificial intelligence (68.2%). Over two-thirds were aware of ChatGPT. Most students (n= 139, 65.9%) perceived potential benefits in using ChatGPT for various clinical tasks, with concerns including over-reliance, accuracy, and ethical considerations. Adoption of ChatGPT in clinical training varied, with some students not using it at all, while others utilized it for tasks like evaluating drug-drug interactions and developing care plans. Previous users tended to have higher perceived benefits and lower concerns, but the differences were not statistically significant. Conclusion: Utilizing ChatGPT in clinical training offers opportunities, but students' lack of trust in it for clinical decisions highlights the need for collaborative human-ChatGPT decision-making. It should complement healthcare professionals' expertise and be used strategically to compensate for human limitations. Further research is essential to optimize ChatGPT's effective integration.
AI snapshot
Written from the paper’s full text.
TL;DR
This cross-sectional survey of 211 Jordanian PharmD students found that most perceived potential benefits of ChatGPT for clinical training, especially for treatment-related problems and drug-drug interactions, but many had concerns about accuracy, over-reliance, ethics, and accessibility. Adoption was limited, and prior users reported higher perceived benefits and lower concerns, though not statistically significant.
Key findings
- Among 211 PharmD students, 68.2% had prior AI experience and 68.7% were aware of ChatGPT; 65.9% (n=139) believed PharmD students could benefit from ChatGPT, while only 39.8% believed it could provide accurate clinical practice information.
- Perceived benefits included expediting identification/management of treatment-related problems (57.3%, n=121), drug-drug interactions (54.5%, n=115), and adverse drug reactions (50.2%, n=106).
- Concerns included over-reliance/critical thinking, accuracy/reliability, and contextual understanding (each 61.1%, n=129), accessibility/digital divide (58.8%, n=124), ethical/privacy issues (51.2%, n=108), and bias in training data (50.2%, n=106).
- Adoption varied: 46.4% (n=98) never used ChatGPT in clinical training, 12.8% (n=27) used it frequently, 53.1% (n=112) were somewhat/very likely to use it in future practice, and 63% (n=123) would recommend it; among 113 ever-users, 72.6% used it for drug/disease information and 64.6% for drug-drug interactions.
Methods
- Cross-sectional online questionnaire conducted April–May 2023 among PharmD students at the two public pharmacy schools in Jordan, using convenient sampling via Facebook and WhatsApp; 211 students participated, above the minimum calculated sample size of 86.
- The questionnaire had four parts: demographics, perceived benefits (16 items), concerns (8 items), and experience with ChatGPT; benefits and concerns were rated on a 5-point Likert scale, with stated score ranges of 16–80 for benefits and 9–45 for concerns.
- Analysis used SPSS version 25; normality was assessed with Kolmogorov–Smirnov and histograms, showing non-normal distribution; Mann–Whitney U-test compared users and non-users, with p<0.05 significant, and Table 6 notes Kruskal–Wallis tests for future intent and recommendation.
Limitations
- The paper states it did not examine the effect of ChatGPT use on the accuracy of students’ clinical decisions or patient outcomes; convenience and snowball sampling may introduce selection bias; and social media recruitment prevents calculation of a survey response rate.
- Evident inconsistencies in the text include gender reporting: the narrative says the majority were male (n=163, 77.3%), while Table 1 lists male as 48 (22.7%) and female as 163 (77.3%).
- Additional evident issues include Table 2 being labeled N=221 despite the study sample of 211, and the concern score range being described as 9–45 for 8 items.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 3 cited sources checked · 0 supported · 0 flagged
- Findingown data
38.9% (n=82) of participants agreed or strongly agreed that ChatGPT can assist in identifying wrong medications prescribed to the patient.
“Chat GPT can assist in identifying wrong medications prescribed to the patient. | 82 (38.9) | 73 (34.6) | 56 (26.5)”
Quote in the paperNot a substantial claim - Findingown data
50.2% (n=106) of participants agreed or strongly agreed that ChatGPT may have bias in its training data, resulting in biased responses or recommendations.
“Bias in data: There is a possibility that ChatGPT may have bias in its training data, which could result in biased responses or recommendations. | 106 (50.2) | 64 (30.3) | 41 (19.4)”
Quote in the paperNot a substantial claim - Findingown data
46.0% (n=97) of participants agreed or strongly agreed that ChatGPT can assist in therapeutic drug monitoring.
“Chat GPT can assist in therapeutic drug monitoring. | 97 (46.0) | 69 (32.7) | 45 (21.3)”
Quote in the paperNot a substantial claim - Findingown data
68.7% (n=145) of participants were aware of ChatGPT.
“over two-thirds of the participants (n= 145, 68.7%) were aware of ChatGPT.”
Quote in the paperNot a substantial claim - Findingown data
46.4% (n=98) of participants agreed or strongly agreed that ChatGPT can assist in clinical pharmacokinetic calculations.
“Chat GPT can assist in clinical pharmacokinetic calculations. | 98 (46.4) | 64 (30.3) | 49 (23.2)”
Quote in the paperNot a substantial claim
- Findingown data
46.4% (n=98) of students did not use ChatGPT in their clinical training.
“Almost half of the students (n= 98, 46.4%) did not use ChatGPT in their clinical training”
Quote in the paperNot a substantial claim - Findingown data
58.3% (n=123) of participants agreed or strongly agreed that ChatGPT may not be able to provide the same level of personal interaction and feedback that students may require in their training.
“Lack of personal interaction: ChatGPT may not be able to provide the same level of personal interaction and feedback that students may require in their training | 123 (58.3) | 52 (24.6) | 36 (17.1)”
Quote in the paperNot a substantial claim - Findingown data
38.9% (n=82) of participants agreed or strongly agreed that ChatGPT can assist in making treatment decisions for patients.
“ChatGPT can assist in making treatment decisions for patients | 82 (38.9) | 66 (31.3) | 63 (29.9)”
Quote in the paperNot a substantial claim - Findingown data
39.8% (n=84) of participants agreed or strongly agreed that ChatGPT can provide accurate information related to clinical practice.
“ChatGPT can provide accurate information related to clinical practice | 84 (39.8) | 80 (37.9) | 47 (22.3)”
Quote in the paperNot a substantial claim - Findingown data
65.9% (n=139) of participants agreed or strongly agreed that PharmD students can benefit from using ChatGPT.
“PharmD students can benefit from using ChatGPT | 139 (65.9) | 49 (23.2) | 23 (10.9)”
Quote in the paperNot a substantial claim - Findingown data
44.5% (n=94) of participants agreed or strongly agreed that ChatGPT can be used for medication reconciliation to ensure accuracy of patient medication lists.
“Chat GPT can be used for medication reconciliation to ensure accuracy of patient medication lists. | 94 (44.5) | 68 (32.2) | 49 (23.2)”
Quote in the paperNot a substantial claim - Findingown data
61.1% (n=129) of participants agreed or strongly agreed that ChatGPT may not be able to understand the context of a particular situation or question, resulting in incorrect or inadequate responses.
“Lack of contextual understanding: ChatGPT may not be able to understand the context of a particular situation or question, which could result in incorrect or inadequate responses. | 129 (61.1) | 49 (23.2) | 33 (15.6)”
Quote in the paperNot a substantial claim - Findingown data
57.3% (n=121) of participants agreed or strongly agreed that ChatGPT can save time in the process of identifying and managing treatment-related problems.
“Chat GPT can save time in the process of identifying and managing treatment-related problems | 121 (57.3) | 51 (24.2) | 39 (18.5)”
Quote in the paperNot a substantial claim - Findingown data
36.5% (n=77) of participants agreed or strongly agreed that ChatGPT can help in identifying not needed medications prescribed to the patient.
“Chat GPT can help in identifying not needed medications prescribed to the patient. | 77 (36.5) | 74 (35.1) | 60 (17.2)”
Quote in the paperNot a substantial claim - Findingown data
50.2% (n=106) of participants agreed or strongly agreed that ChatGPT can assist in identifying and managing adverse drug reactions.
“Chat GPT can assist in identifying and managing adverse drug reactions. | 106 (50.2) | 65 (30.8) | 40 (19.0)”
Quote in the paperNot a substantial claim - Findingown data
43.6% (n=92) of participants agreed or strongly agreed that ChatGPT can aid in developing pharmacological pharmaceutical care plans.
“Chat GPT can aid in developing pharmacological pharmaceutical care plans. | 92 (43.6) | 68 (32.2) | 51 (24.2)”
Quote in the paperNot a substantial claim - Findingown data
61.1% (n=129) of participants agreed or strongly agreed that there is a possibility of errors and inaccuracies in ChatGPT's responses.
“Accuracy and reliability: Although ChatGPT has advanced natural language processing capabilities, there is still a possibility of errors and inaccuracies in its responses | 129 (61.1) | 57 (27.0) | 25 (11.8)”
Quote in the paperNot a substantial claim - Findingown data
55.5% (n=117) of participants agreed or strongly agreed that ChatGPT may not be able to cover all necessary topics and information required for pharmacy practice.
“Limited scope: ChatGPT may not be able to cover all the necessary topics and information required for pharmacy practice, and may not be able to provide comprehensive training to students. | 117 (55.5) | 56 (26.5) | 38 (18.0)”
Quote in the paperNot a substantial claim - Findingown data
46.9% (n=99) of participants agreed or strongly agreed that ChatGPT can assist in patient education by providing accurate information about medications.
“Chat GPT can assist in patient education by providing accurate information about medications. | 99 (46.9) | 71 (33.6) | 41 (19.4)”
Quote in the paperNot a substantial claim - Findingown data
54.5% (n=115) of participants agreed or strongly agreed that drug-drug interactions can be easily identified and managed with the help of ChatGPT.
“Drug-drug interactions can be easily identified and managed with the help of Chat GPT. | 115 (54.5) | 60 (28.4) | 36 (17.1)”
Quote in the paperNot a substantial claim - Findingown data
48.3% (n=102) of participants agreed or strongly agreed that ChatGPT can aid in developing non-pharmacological pharmaceutical care plans.
“Chat GPT can aid in developing non-pharmacological pharmaceutical care plans. | 102 (48.3) | 70 (33.2) | 39 (18.5)”
Quote in the paperNot a substantial claim - Findingown data
32.7% (n=69) of participants agreed or strongly agreed that ChatGPT can help in determining appropriate dosage regimens for patients.
“Chat GPT can help in determining appropriate dosage regimens for patients. | 69 (32.7) | 73 (34.6) | 69 (32.7)”
Quote in the paperNot a substantial claim - Findingown data
35.5% (n=75) of participants agreed or strongly agreed that ChatGPT can aid in identifying further medications needed for the patient's treatment.
“Chat GPT can aid in identifying further medications needed for the patient’s treatment. | 75 (35.5) | 85 (40.3) | 51 (24.2)”
Quote in the paperNot a substantial claim - Findingown data
60.2% (n=127) of participants agreed or strongly agreed that there is a risk students may rely too heavily on ChatGPT and neglect other important sources of learning and training.
“Over-reliance on ChatGPT: There is a risk that students may rely too heavily on ChatGPT, and may neglect other important sources of learning and training. | 127 (60.2) | 50 (23.7) | 34 (16.1)”
Quote in the paperNot a substantial claim - Findingown data
51.2% (n=108) of participants agreed or strongly agreed that the use of ChatGPT in pharmacy training may raise ethical concerns such as patients' privacy and confidentiality.
“Ethical concerns: The use of ChatGPT in pharmacy training may raise ethical concerns, such as issues related to patients’ privacy and confidentiality. | 108 (51.2) | 53 (25.1) | 50 (23.7)”
Quote in the paperNot a substantial claim - Findingreasoning
Participants expressed ethical doubts regarding patient privacy.
“Ethical doubts that the participants expressed regarding the patient’s privacy are a legitimate concern.”
Quote in the paperNot a substantial claim - Findingown data
46.2% of Pharm-D students found ChatGPT equally helpful for developing non-pharmacological care plans compared to human-made decisions.
“In terms of developing pharmaceutical care plans, students indicated a higher level of perceived usefulness for non-pharmacological care plans, with 46.2% finding ChatGPT equally helpful and 27.7% finding it more helpful compared to human-made decisions.”
Quote in the paperNot a substantial claim - Findingown data
63% (n=123) of participants would recommend ChatGPT's use for pharmacy students and preceptors.
“63% (n= 123) would recommend it”
Quote in the paperNot a substantial claim - Findingown data
Among 113 ever-users, 64.5% (n=74) used ChatGPT to identify or manage adverse drug reactions.
“To identify or manage adverse drug reactions | 74 (64.5)”
Quote in the paperNot a substantial claim - Findingown data
Among 113 ever-users, 58.4% (n=66) used ChatGPT to aid in therapeutic drug monitoring.
“To aid you in therapeutic drug monitoring | 66 (58.4)”
Quote in the paperNot a substantial claim - Findingown data
12.8% (n=27) of students used ChatGPT frequently (once a week or more) in their clinical training.
“only a minority (n= 27, 12.8%) having used it frequently”
Quote in the paperNot a substantial claim - Findingown data
53.1% (n=112) of participants indicated they were somewhat likely or very likely to incorporate ChatGPT into their future clinical practice.
“over half (n= 112, 53.1%) indicated that they were somewhat likely or very likely to do so.”
Quote in the paperNot a substantial claim - Findingown data
55.6% of Pharm-D students found ChatGPT equally helpful for determining appropriate dosage regimens compared to other standard resources.
“Only 13% of participants reported finding ChatGPT “more helpful”, while a larger percentage (55.6%) indicated that it was “equally helpful” compared to other standard resources.”
Quote in the paperNot a substantial claim - Findingown data
Among 113 ever-users, 64.6% (n=72) used ChatGPT to check for drug-drug interactions.
“To check for Drug-drug interactions? | 72 (64.6)”
Quote in the paperNot a substantial claim - Findingown data
Nearly half of the participants had not used ChatGPT.
“While nearly half had not used ChatGPT, many expressed future intent.”
Quote in the paperNot a substantial claim - Findingown data
Among 113 ever-users, 55.8% (n=63) used ChatGPT to aid in developing a pharmacological pharmaceutical care plan.
“To aid you in developing a pharmacological pharmaceutical care plan | 63 (55.8)”
Quote in the paperNot a substantial claim - Findingown data
Among 113 ever-users, 70.8% (n=80) used ChatGPT to aid in developing a non-pharmacological pharmaceutical care plan.
“To aid you in developing a non-pharmacological pharmaceutical care plan (diet, lifestyle modifications)? | 80 (70.8)”
Quote in the paperNot a substantial claim - Findingown data
41.5% of Pharm-D students reported equal helpfulness for pharmacological care plans compared to human-made decisions.
“This contrasts with pharmacological care plans, where 41.5% reported equal helpfulness and 21.3% reported more helpfulness.”
Quote in the paperNot a substantial claim - Findingown data
Among 113 ever-users, 56.6% (n=64) used ChatGPT to aid in clinical pharmacokinetic calculations.
“To aid you in clinical pharmacokinetic calculations? | 64 (56.6)”
Quote in the paperNot a substantial claim - Findingown data
Among Pharm-D students surveyed, 59.3% (67/113) used ChatGPT for determining appropriate dosage regimens.
“Approximately one-third of participants expressed employing ChatGPT for medication reconciliation (n= 66/113, 58.4%) and determining appropriate dosage regimens (n= 67/113, 59.3%).”
Quote in the paperSubstantial claim - Findingown data
Many participants expressed future intent to use ChatGPT.
“While nearly half had not used ChatGPT, many expressed future intent.”
Quote in the paperNot a substantial claim - Findingown data
11.4% (n=24) of participants would not recommend ChatGPT.
“11.4% (n= 24) would not recommend it.”
Quote in the paperNot a substantial claim - Findingown data
Among Pharm-D students surveyed, 55.7% (63/113) used ChatGPT to aid in the development of pharmacological pharmaceutical care plans.
“Moreover, 55.7% of the participants (n= 63/113) utilized ChatGPT to aid in the development of pharmacological pharmaceutical care plans.”
Quote in the paperSubstantial claim - Findingown data
25.6% (n=54) of participants remained undecided about recommending ChatGPT.
“25.6% (n= 54) remained undecided”
Quote in the paperNot a substantial claim - Findingown data
Participants who would definitely recommend ChatGPT had higher perceived benefit scores (median 3.8, p<0.001).
“Additionally, those more likely to recommend ChatGPT (“Yes, definitely”) presented higher perceived benefit scores (3.8 with a p-value < 0.001).”
Quote in the paperNot a substantial claim - Findingown data
19.8% of Pharm-D students found ChatGPT more helpful for therapeutic drug monitoring.
“When considering therapeutic drug monitoring, a notable 48.1% of participants found ChatGPT to be “equally helpful”, 32.1% reported finding it “less helpful”, while 19.8% found it “more helpful”.”
Quote in the paperNot a substantial claim - Findingown data
30.9% of Pharm-D students found ChatGPT more helpful for clinical pharmacokinetic calculations compared to other calculation tools.
“For clinical pharmacokinetic calculations, approximately 39.1% of participants found ChatGPT to be “equally helpful”, while 30.9% considered it “more helpful” compared to other calculation tools.”
Quote in the paperNot a substantial claim - Findingnone given
The most positively received functionality of ChatGPT by participants who used it, compared to other sources typically used for assessing drug interactions, was drug-drug interactions.
“The most positively received functionality of the ChatGPT by the participants who used it, compared to other sources typically utilized for assessing drug interactions, was drug-drug interactions.”
Quote in the paperNot a substantial claim - Findingown data
21.3% of Pharm-D students reported more helpfulness for pharmacological care plans compared to human-made decisions.
“This contrasts with pharmacological care plans, where 41.5% reported equal helpfulness and 21.3% reported more helpfulness.”
Quote in the paperNot a substantial claim - Findingnone given
Only one-third of participants thought ChatGPT was utilized to identify more sophisticated tasks such as wrongly prescribed medications, unnecessary medications, and dosage forms.
“Only one-third thought the ChatGPT utilized it to identify more sophisticated tasks such as wrongly prescribed medications, unnecessary medications, and dosage forms.”
Quote in the paperNot a substantial claim - Findingown data
48.1% of Pharm-D students found ChatGPT equally helpful for therapeutic drug monitoring.
“When considering therapeutic drug monitoring, a notable 48.1% of participants found ChatGPT to be “equally helpful”, 32.1% reported finding it “less helpful”, while 19.8% found it “more helpful”.”
Quote in the paperNot a substantial claim - Findingown data
39.1% of Pharm-D students found ChatGPT equally helpful for clinical pharmacokinetic calculations compared to other calculation tools.
“For clinical pharmacokinetic calculations, approximately 39.1% of participants found ChatGPT to be “equally helpful”, while 30.9% considered it “more helpful” compared to other calculation tools.”
Quote in the paperNot a substantial claim - Findingown data
Among Pharm-D students surveyed, 70.8% (80/113) used ChatGPT for the development of non-pharmacological pharmaceutical care plans.
“Notably, a higher proportion of respondents (n= 80/113, 70.8%) had utilized ChatGPT for the development of non-pharmacological pharmaceutical care plans.”
Quote in the paperNot a substantial claim - Findingown data
Among 113 ever-users, 59.3% (n=67) used ChatGPT to determine appropriate dosage regimens for patients.
“To determine appropriate dosage regimens for patients | 67 (59.3)”
Quote in the paperNot a substantial claim - Findingown data
Among 113 ever-users, 72.6% (n=82) used ChatGPT to obtain drug and disease information.
“To obtain drug and disease information (for example: ask Chat GPT questions about particular conditions, treatments, medications, or lifestyle changes) | 82 (72.6)”
Quote in the paperNot a substantial claim - Findingown data
27.7% of Pharm-D students found ChatGPT more helpful for developing non-pharmacological care plans compared to human-made decisions.
“In terms of developing pharmaceutical care plans, students indicated a higher level of perceived usefulness for non-pharmacological care plans, with 46.2% finding ChatGPT equally helpful and 27.7% finding it more helpful compared to human-made decisions.”
Quote in the paperNot a substantial claim - Findingown data
32.1% of Pharm-D students found ChatGPT less helpful for therapeutic drug monitoring.
“When considering therapeutic drug monitoring, a notable 48.1% of participants found ChatGPT to be “equally helpful”, 32.1% reported finding it “less helpful”, while 19.8% found it “more helpful”.”
Quote in the paperNot a substantial claim - Findingown data
Among 113 ever-users, 58.4% (n=66) used ChatGPT for medication reconciliation.
“For medication reconciliation | 66 (58.4)”
Quote in the paperNot a substantial claim - Findingown data
Among Pharm-D students surveyed, 56.6% (64/113) used ChatGPT for clinical pharmacokinetic calculations.
“Interestingly, ChatGPT’s utility extended to aiding students in therapeutic drug monitoring (n= 67/113, 59.3%) and clinical pharmacokinetic calculations (n= 64/113, 56.6%), highlighting its potential in supporting complex clinical decision-making processes.”
Quote in the paperSubstantial claim - Findingown data
Among Pharm-D students surveyed, 58.4% (66/113) used ChatGPT for medication reconciliation.
“Approximately one-third of participants expressed employing ChatGPT for medication reconciliation (n= 66/113, 58.4%) and determining appropriate dosage regimens (n= 67/113, 59.3%).”
Quote in the paperSubstantial claim - Findingown data
13% of Pharm-D students found ChatGPT more helpful for determining appropriate dosage regimens compared to other standard resources.
“Only 13% of participants reported finding ChatGPT “more helpful”, while a larger percentage (55.6%) indicated that it was “equally helpful” compared to other standard resources.”
Quote in the paperNot a substantial claim - Findingreasoning
Most participants agreed on the usefulness of ChatGPT for non-pharmacological care plans.
“Most participants agreed on the usefulness of ChatGPT for non-pharmacological care plans.”
Quote in the paperNot a substantial claim - Findingown data
Among Pharm-D students surveyed, 59.3% (67/113) used ChatGPT for therapeutic drug monitoring.
“Interestingly, ChatGPT’s utility extended to aiding students in therapeutic drug monitoring (n= 67/113, 59.3%) and clinical pharmacokinetic calculations (n= 64/113, 56.6%), highlighting its potential in supporting complex clinical decision-making processes.”
Quote in the paperNot a substantial claim - Findingown data
Over 80% of Pharm-D students indicated ChatGPT's utility in checking drug-drug interactions was either 'equally helpful' or 'more helpful' compared to other resources typically used for assessing drug interactions.
“Remarkably, over 80% of respondents indicated that ChatGPT’s utility in this domain was either “equally helpful” or “more helpful” compared to other resources typically utilized for assessing drug interactions.”
Quote in the paperNot a substantial claim - Study design and conductreasoning
The minimum recommended sample size for the study was 86 participants, estimated using Raosoft with a 10% margin of error, 95% confidence level, population size 800, and response distribution 50%.
“With a margin of error (d) of 10%, a confidence level of 95%, a population size of 800 PharmD students, and a response distribution (P) of 50%, the minimum recommended sample size was 86 participants.”
Quote in the paperNot a substantial claim - Interpretationown data
Utilizing ChatGPT in clinical training offers opportunities.
“Utilizing ChatGPT in clinical training offers opportunities”
Quote in the paperSubstantial claim - Premisecitation
The accuracy, reliability, and practical viability of ChatGPT in real-world clinical pharmacy settings have yet to be comprehensively explored.
“However, despite the promise, the accuracy, reliability, and practical viability of ChatGPT in real-world clinical pharmacy settings have yet to be comprehensively explored.1,10”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [1] Huang, 2023, Br J Clin Pharmacol
Not checked in the free run.
- cites [10] Zhu Y, Han D, Chen S, Zeng F, Wang C. How can chatgpt benefit pharmacy: a case report on review writing; 2023. source
Not checked in the free run.
- Interpretationown data
PharmD students lack trust in ChatGPT for clinical decisions.
“students’ lack of trust in it for clinical decisions”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 16
- May combine two claims. 11
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown data85.3% (n=180) of participants indicated they have good to excellent proficiency in computer and digital technology usage.
“the majority (n= 180, 85.3%) indicating they have good to excellent proficiency.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown data68.2% (n=144) of participants had prior experience with artificial intelligence.
“over two-thirds of participants (n= 144, 68.2%) had prior experience with artificial intelligence.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown data49.8% (n=105) of participants were from the Jordan University of Science and Technology.
“49.8% (n= 105) from the Jordan University of Science and Technology”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown data50.2% (n=106) of participants were from the University of Jordan.
“50.2% (n= 106) from the University of Jordan”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data61.1% (n=129) of participants agreed or strongly agreed that students may become overly reliant on ChatGPT and may not develop necessary critical thinking and problem-solving skills.
“Dependence on technology: Students may become overly reliant on ChatGPT and may not develop the necessary critical thinking and problem-solving skills that are essential for the practice of pharmacy | 129 (61.1) | 48 (22.7) | 34 (16.1)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe majority of participants were male (n=163, 77.3%).
“the majority were males (n= 163, 77.3%)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown data58.8% (n=124) of participants agreed or strongly agreed that some students may not have access to necessary technology or resources to effectively use ChatGPT, creating disparities in learning opportunities.
“Accessibility: Some students may not have access to the necessary technology or resources to effectively use ChatGPT in their training, which could create disparities in learning opportunities. | 124 (58.8) | 54 (25.6) | 33 (24.0)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe median age of the 211 participants was 23 years (IQR=1.0).
“The median age of participants was 23 years (IQR= 1.0)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataOver half of the respondents were sixth-year students (n=120, 56.9%).
“over half of the respondents were sixth-year students (n= 120, 56.9%)”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataParticipants more inclined to use ChatGPT in future clinical practice tended to have lower concern scores, with a statistically significant correlation (p=0.038 for those 'Somewhat likely' to use).
“However, participants more inclined to use ChatGPT in future clinical practice tended to exhibit lower concern scores, showing a statistically significant correlation (p-value of 0.038 for those “Somewhat likely” to use).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataPrevious ChatGPT users had lower perceived concerns scores than non-users, but the difference was not statistically significant (P>0.05).
“When comparing previous experience in using ChatGPT with their perceived benefit and concern scores (Table 6), previous users showed higher perceived benefit perception scores and lower perceived concerns scores compared to non-users, but these differences were not statistically significant (P>0.05 for both).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataTwo-thirds of participants believed ChatGPT offers them benefits, especially in identification of treatment-related problems, drug-drug interactions, and adverse drug reactions.
“Results revealed that two-thirds of the participants believed that ChatGPT offers them benefits, especially in the identification of treatment-related problems, drug-drug interactions, and adverse drug reactions participants.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataParticipants expressed skepticism about ChatGPT's accuracy in clinical information provision, with less than half believing it could produce accurate information.
“The accuracy of the data provided by the ChatGPT was questionable, and less than half of the participants believed it could produce accurate information.”
- Also stated in: § Conclusion · plain
“Participants acknowledged potential benefits in expediting treatment-related problem identification and drug interactions but expressed skepticism about its accuracy in clinical information provision.”
Quote in the paperSubstantial claim- Also stated in: § Conclusion · plain
May combine two claims.
Findingown dataPrevious ChatGPT users had higher perceived benefit scores than non-users, but the difference was not statistically significant (P>0.05).
“When comparing previous experience in using ChatGPT with their perceived benefit and concern scores (Table 6), previous users showed higher perceived benefit perception scores and lower perceived concerns scores compared to non-users, but these differences were not statistically significant (P>0.05 for both).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationMany participants agreed that ChatGPT can be helpful in providing patient education.
“Many participants agreed that ChatGPT can be helpful in providing patient education.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataSignificant concerns included over-reliance, digital divide implications, compromised personal interaction, and ethical considerations.
“Significant concerns included over-reliance, digital divide implications, compromised personal interaction, and ethical considerations.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPrevious users of ChatGPT tended to have higher perceived benefits and lower concerns than non-users, but the differences were not statistically significant.
“Previous users tended to have higher perceived benefits and lower concerns, but the differences were not statistically significant.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe study questionnaire was evaluated for content and face validity by two survey experts.
“The initial study questionnaire was generated and evaluated for content and face validity by two survey experts.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenEthical approval for the study was granted by the Institutional Review Board at the Jordan University Hospital (Approval number: 10/2023/16,283).
“Ethical approval for the study was granted by the Institutional Review Board at the Jordan University Hospital (Approval number: 10/2023/16,283).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe study was conducted following the Declaration of Helsinki of the World Medical Association.
“The current study was conducted following the Declaration of Helsinki of the World Medical Association.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataData normality was examined using the Kolmogorov-Smirnov test and histogram visualizations, revealing a non-normal distribution (p < 0.05).
“The data normality was examined using the Kolmogorov–Smirnov test and histogram visualizations, revealing a non-normal distribution. The test yielded a significant result (p < 0.05), affirming this non-normal distribution.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe integration of AI-powered tools into clinical pharmacy practices could bolster efficiency, decision-making, and patient outcomes.
“The integration of AI-powered tools into clinical pharmacy practices could bolster efficiency, decision-making, and patient outcomes.9”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Liu, 2023, J Am Med Inform Assoc source
Not checked in the free run.
May combine two claims.
Study design and conductnone givenData collection relied on convenience and snowball sampling techniques, which may introduce selection bias.
“Also, data collection relied on convenience and snowball sampling techniques, which may introduce selection bias.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationCommunication with patients seems to be an area where ChatGPT can be very helpful.
“Communication with patients seems to be an area where ChatGPT can be very helpful.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThe correlations suggest a link between users' attitudes towards ChatGPT, their perceived benefits, and concerns, potentially influencing their inclination to use or recommend it in clinical practice.
“These correlations suggest a link between users’ attitudes towards ChatGPT, their perceived benefits, and concerns, potentially influencing their inclination to use or recommend it in clinical practice.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe study did not examine the effect of ChatGPT utilization by students on the accuracy of their clinical decisions or patient outcomes.
“However, one limitation of the study is that it did not examine the effect of ChatGPT utilization by students on the accuracy of their clinical decisions or patient outcomes.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Study design and conductnone givenUtilizing social media for participant recruitment prevents the calculation of a survey response rate.
“Moreover, utilizing social media for participant recruitment prevents the calculation of a survey response rate.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The integration of ChatGPT into pharmacy practice training remains to be investigated.
“Yet, the integration of ChatGPT to pharmacy practice training remains to be investigated.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
AI technologies could serve as complementary tools to support, rather than replace, human expertise.
“This suggests that AI technologies could serve as complementary tools to support, rather than replace, human expertise [32, 40].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Reported majority-male sample conflicts with the gender table
MajorThe text says 163 participants were male, but Table 1 assigns 163 participants to the female category and 48 to the male category.
“the majority were males (n= 163, 77.3%).”
“| ○ Male | | 48 (22.7) | | ○ Female | | 163 (77.3) |”
Incorrect percentage for disagreement about unnecessary medications
MinorThe reported 60 students represent 28.4% of the 211 participants, not 17.2%.
Reported 17.2 · recomputed 28.436019
“| Chat GPT can help in identifying not needed medications prescribed to the patient. | 77 (36.5) | 74 (35.1) | 60 (17.2) |”
Recommendation count does not match its table categories
MinorTable 4 lists 39 students who would definitely recommend ChatGPT and 94 who would probably recommend it, totaling 133 rather than the stated 123. The stated 63% is consistent with 133 of 211.
Reported 123 · recomputed 133
“63% (n= 123) would recommend it”
Incorrect percentage for those not at all likely to use ChatGPT
MinorFifteen of 211 participants represent 7.1%, not 7.3%.
Reported 7.3 · recomputed 7.109005
“| a) Not at all Likely | | 15 (7.3) |”
Incorrect percentage for adverse-drug-reaction use
MinorAmong 113 previous users, 74 represent 65.5%, not the 64.5% printed in Table 5. The accompanying text gives 65.5%.
Reported 64.5 · recomputed 65.486726
“| To identify or manage adverse drug reactions | 74 (64.5) |”
Therapeutic-drug-monitoring use differs between text and table
MinorThe text reports 67 of 113 users, while Table 5 reports 66 users for the same task.
“aiding students in therapeutic drug monitoring (n= 67/113, 59.3%)”
“| To aid you in therapeutic drug monitoring | 66 (58.4) |”
Incorrect accessibility-concern percentage
MinorThe 33 students in the disagreement category represent 15.6% of 211, not 24.0%.
Reported 24 · recomputed 15.63981
“| Accessibility: Some students may not have access to the necessary technology or resources to effectively use ChatGPT in their training, which could create disparities in learning opportunities. | 124 (58.8) | 54 (25.6) | 33 (24.0) |”
Table 2 gives a different sample size
MinorTable 2 is labeled N=221, whereas the study reports 211 students. Its first row also contains 211 responses.
“Table: Table 2 Students’ Perceived Benefits of ChatGPT Integration in Clinical Training (N= 221)”
“Table 1 provides an overview of the sociodemographic characteristics of the 211 students recruited in this study.”
Concern-score maximum does not match eight five-point items
MinorEight items scored from 1 to 5 would have a total-score range of 8 to 40, not the stated 9 to 45.
Reported 45 · recomputed 40
“A 5-point Likert scale ranging from strongly disagree to strongly agree was utilized to evaluate the students’ perceived benefits and concerns, with scores ranging from 1 to 5, respectively. So, the scores for perceived benefits (16 items) ranged from 16 to 80, and the overall score for perceived concerns (8 items) ranged from 9 to a max score of 45.”
Cites
Cascella, M., Montomoli, J., Bellini, V., & Bignami, E. (2023) · Journal of Medical Systems · doi:10.1007/s10916-023-01925-4 · Cited by 1,120 · see citing works
ChatGPT and other large language models are double-edged swords
Shen, Y., Heacock, L., Elias, J., Hentel, K. D., Reig, B., Shih, G., & Moy, L. (2023) · Radiology · doi:10.1148/radiol.230163 · Cited by 1,008 · see citing works
The role of AI in drug discovery: challenges, opportunities, and strategies
Blanco-González, A., Cabezón, A., Seco-González, A., Conde-Torres, D., Antelo-Riveiro, P., Piñeiro, Á., & Garcia-Fandino, R. (2023) · Pharmaceuticals · doi:10.3390/ph16060891 · Cited by 690 · see citing works
Human- versus Artificial Intelligence
Korteling, J. E. (., van de Boer-Visschedijk, G. C., Blankendaal, R. A. M., Boonekamp, R. C., & Eikelboom, A. R. (2021) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2021.622364 · Cited by 619 · see citing works
The benefits and challenges of chatgpt: An overview
Deng, J., & Lin, Y. (2023) · Frontiers in Computing and Intelligent Systems · doi:10.54097/fcis.v2i2.4465 · Cited by 611 · see citing works
Transformative Effects of ChatGPT on Modern Education: Emerging Era of AI Chatbots
Gill, S. S., Xu, M.-X., Patros, P., Wu, H.-M., Kaur, R., Kaur, K., Fuller, S., Singh, M., Arora, P., Parlikad, A., et al. (2023) · Internet Things Cyber Phys. Syst. · doi:10.1016/j.iotcps.2023.06.002 · Cited by 466 · see citing works
Sarraju, A., Bruemmer, D., Iterson, E. H. V., Cho, L., Rodríguez, F., & Laffin, L. J. (2023) · JAMA · doi:10.1001/jama.2023.1044 · Cited by 455 · see citing works
Rao, A., Pang, M., Kim, J., Kamineni, M., Lie, W., Prasad, A. K., Landman, A., Dreyer, K., & Succi, M. D. (2023) · Journal of Medical Internet Research · doi:10.2196/48659 · Cited by 412 · see citing works
Using AI-generated suggestions from ChatGPT to optimize clinical decision support
Liu, S., Wright, A. P., Patterson, B. L., Wanderer, J. P., Turer, R. W., Nelson, S. D., McCoy, A. B., Sittig, D. F., & Wright, A. (2023) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocad072 · Cited by 397 · see citing works
Lecler, A., Duron, L., & Soyer, P. (2023) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2023.02.003 · Cited by 385 · see citing works
The Future of AI in Medicine: A Perspective from a Chatbot
King, M. R. (2023) · Annals of Biomedical Engineering · doi:10.1007/s10439-022-03121-w · Cited by 299 · see citing works
The exciting potential for ChatGPT in obstetrics and gynecology
Grünebaum, A., Chervenak, J., Pollet, S. L., Katz, A., & Chervenak, F. A. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.03.009 · Cited by 234 · see citing works
Bonsu, E. M., & Baffour-Koduah, D. (2023) · Journal of Education Society & Multiculturalism · doi:10.2478/jesm-2023-0001 · Cited by 179 · see citing works
Temsah, M.-H., Aljamaan, F., Malki, K. H., Alhasan, K., Altamimi, I., Aljarbou, R., Bazuhair, F., Alsubaihin, A., Abdulmajeed, N., Alshahrani, F. S., et al. (2023) · Healthcare · doi:10.3390/healthcare11131812 · Cited by 179 · see citing works
Sallam, M., Salim, N. A., Al-Tammemi, A. B., Barakat, M., Fayyad, D., Hallit, S., Harapan, H., Hallit, R., & Mahafzah, A. (2023) · Cureus · doi:10.7759/cureus.35029 · Cited by 130 · see citing works
Al-Ashwal, F. Y., Zawiah, M., Gharaibeh, L., Abu-Farha, R., & Bitar, A. N. (2023) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s425858 · Cited by 125 · see citing works
Self-citationHuang, X., Estau, D., Liu, X., Yu, Y., Qin, J., & Li, Z. (2023) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15896 · Cited by 117 · see citing works
Zong, H., Li, J., Wu, E., Wu, R., Lu, J., & Shen, B. (2024) · BMC Medical Education · doi:10.1186/s12909-024-05125-7 · Cited by 114 · see citing works
Performance of ChatGPT on the pharmacist licensing examination in Taiwan
Wang, Y.-M., Shen, H.-W., & Chen, T.-J. (2023) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000942 · Cited by 109 · see citing works
Gala, D., & Makaryus, A. N. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20156438 · Cited by 94 · see citing works
Performance and risks of ChatGPT used in drug information: an exploratory real-world analysis
Morath, B., Chiriac, U., Jaszkowski, E., Deiß, C., Nürnberg, H., Hörth, K., Hoppe‐Tichy, T., & Green, K. (2023) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2023-003750 · Cited by 79 · see citing works
Al-Dujaili, Z., Omari, S., Pillai, J., & Al Faraj, A. (2023) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2023.08.012 · Cited by 56 · see citing works
Kusunose, K., Kashima, S., & Sata, M. (2023) · Circulation Journal · doi:10.1253/circj.cj-23-0308 · Cited by 54 · see citing works
Hsu, H.-Y., Hsu, K.-C., Hou, S.-Y., Wu, C.-L., Hsieh, Y.-W., & Cheng, Y.-D. (2023) · JMIR Medical Education · doi:10.2196/48433 · Cited by 50 · see citing works
Park, J. (2023) · Journal of Educational Evaluation for Health Professions · doi:10.3352/jeehp.2023.20.29 · Cited by 43 · see citing works
(2023) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-023-00624-2 · Cited by 42 · see citing works
Self-citationMeo, S. A., Al-Khlaiwi, T., AbuKhalaf, A. A., Meo, A. S., & Klonoff, D. C. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231203987 · Cited by 40 · see citing works
Abu-Farha, R., Fino, L., Al-Ashwal, F. Y., Zawiah, M., Gharaibeh, L., Harahsheh, M. M., & Darwish Elhajji, F. (2023) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2023.08.020 · Cited by 32 · see citing works
Self-citationGalido, P. V., Butala, S., Chakerian, M., & Agustines, D. (2023) · Cureus · doi:10.7759/cureus.38166 · Cited by 29 · see citing works
Rodríguez, F., Ngo, S., Baird, G. L., Balla, S., Miles, R. C., & Garg, M. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017372 · Cited by 28 · see citing works
How Can ChatGPT Benefit Pharmacy: A Case Report on Review Writing
Zhu, Y., Han, D., Chen, S., Zeng, F., & Wang, C. (2023) · doi:10.20944/preprints202302.0324.v1 · Cited by 21 · see citing works
Flagged first, then by citations
Research works printed but not linked: 8
- Huang, 2023, Br J Clin Pharmacol, 2023, 1
- Wang, 2023, J Chin Med Assoc, 10, 1097
- Zong, 2023, medRxiv, 2023, 23292415
- Hammour, 2023, J Pharm Policy Pract, 16
- Liu, 2023, medRxiv, 2023, 1
- Abouammoh, 2023, medRxiv, 2023, 23292624
- Johnson, 2023, Res Sq, 2023, 1
- Sallam, 2023, Cureus, 15, 2
Cited by
Sorted by citations
Pham, T. D., Karunaratne, N., Exintaris, B., Liu, D., Lay, T., Yuriev, E., & Lim, A. (2025) · Medical Education · doi:10.1111/medu.15746 · Cited by 100 · see citing works
Cai, L., Msafiri, M. M., & Kangwa, D. (2025) · Education and Information Technologies · doi:10.1007/s10639-024-13112-0 · Cited by 104 · see citing works
Saúde, S., Barros, J. P., & Almeida, I. A. T. (2024) · Social Sciences · doi:10.3390/socsci13080410 · Cited by 137 · see citing works
Msambwa, M. M., Wen, Z., & Daniel, K. (2025) · European Journal of Education · doi:10.1111/ejed.12909 · Cited by 76 · see citing works
Daniel, K., Msambwa, M. M., & Wen, Z. (2025) · European Journal of Education · doi:10.1111/ejed.70036 · Cited by 71 · see citing works
Abdelwanis, M., Simsekler, M. C. E., Gabor, A. F., Sleptchenko, A., & Omar, M. (2025) · Safety Science · doi:10.1016/j.ssci.2025.107028 · Cited by 79 · see citing works
An automated framework for assessing how well LLMs cite relevant medical references
Wu, K., Wu, E., Wei, K., Zhang, A., Casasola, A., Nguyen, T., Riantawan, S., Shi, P., Ho, D., & Zou, J. (2025) · Nature Communications · doi:10.1038/s41467-025-58551-6 · Cited by 72 · see citing works
“Lack of trust is commonly cited as the number one deterrent against clinicians adopting LLMs in their clinical practice 16,17 , and in particular, the inability of LLMs to generate supporting sources for medical statements in their responses 18 .”
Mortlock, R., & Lucas, C. (2024) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2024.100481 · Cited by 51 · see citing works
Chen, J., Zhu, L., Mou, W., Lin, A., Zeng, D., Qi, C., Liu, Z., Jiang, A., Tang, B., Shi, W., et al. (2024) · iMetaOmics · doi:10.1002/imo2.7 · Cited by 33 · see citing works
Tortella, F., Palese, A., Turolla, A., Castellini, G., Pillastrini, P., Landuzzi, M. G., Cook, C., Galeoto, G., Giovannico, G., Rodeghiero, L., et al. (2025) · BMC Medical Education · doi:10.1186/s12909-025-07176-w · Cited by 28 · see citing works
“Several surveys have also highlighted barriers such as over-reliance on technology [22, 26, 28, 32], concerns about the accuracy and reliability of answers [21, 22, 24, 26, 32, 34, 43], and issues related to plagiarism and lack of transparency [23, 26, 35, 37, 42].”
InfluentialPerceptions of Artificial Intelligence and ChatGPT by Speech-Language Pathologists and Students
Austin, J., Benas, K., Caicedo, S., Imiolek, E., Piekutowski, A., & Ghanim, I. (2025) · American Journal of Speech-Language Pathology · doi:10.1044/2024_ajslp-24-00218 · Cited by 31 · see citing works
A Systematic Review of User Attitudes Toward GenAI: Influencing Factors and Industry Perspectives
Chen, J., Wei, X., Xie, Q., Hu, A., Qiao, Y., Wan, R., & Liu, Y. (2025) · Journal of Intelligence · doi:10.3390/jintelligence13070078 · Cited by 36 · see citing works
Nazaretsky, T., Mejia‐Domenzain, P., Swamy, V., Frej, J., & Käser, T. (2026) · Journal of Computer Assisted Learning · doi:10.1111/jcal.70153 · Cited by 26 · see citing works
Veras, M., Dyer, J.-O., Shannon, H., Bogie, B. J. M., Ronney, M., Sekhon, H., Rutherford, D., Silva, P. G. B., & Kairy, D. (2024) · DIGITAL HEALTH · doi:10.1177/20552076241298485 · Cited by 25 · see citing works
Kattan, L., Moideen, S., Abdelrahman, A., Khabbaz, S., Ibrahim, A. A. E. W., & Mraiche, F. (2025) · Currents in Pharmacy Teaching and Learning · doi:10.1016/j.cptl.2025.102534 · Cited by 22 · see citing works
One year in the classroom with ChatGPT: empirical insights and transformative impacts
Guo, F., Li, T., & Cunningham, C. J. L. (2025) · Frontiers in Education · doi:10.3389/feduc.2025.1574477 · Cited by 32 · see citing works
Sharab, L., Butul, B., & Guha, U. (2024) · The Saudi Dental Journal · doi:10.1016/j.sdentj.2024.11.004 · Cited by 19 · see citing works
Understanding user trust in AI-generated content: an elaboration likelihood model perspective
Zhou, T., & Fang, X. (2025) · Online Information Review · doi:10.1108/oir-01-2025-0041 · Cited by 16 · see citing works
Hammour, A. A., Hammour, K. A., Alhamad, H., Nassar, R., El-Dahiyat, F., Sawaqed, M. I., Allan, A., Manaseer, Q., Abu-Hammour, M., Halboup, A. M., et al. (2024) · Journal of Pharmaceutical Policy and Practice · doi:10.1080/20523211.2024.2429000 · Cited by 11 · see citing works
Basil, M., Ahmed, W., Hajeomar, R., Strawbridge, J., Lynch, M. R., & Mukhalalati, B. (2026) · BMC Medical Education · doi:10.1186/s12909-025-08527-3 · Cited by 13 · see citing works
Eddine, R. J., Gide, E., & Al-Sabbagh, A. (2025) · STEM Education · doi:10.3934/steme.2025035 · Cited by 12 · see citing works
ADVANTAGES AND DRAWBACKS OF CHATGPT IN THE CONTEXT OF DRAFTING SCHOLARLY ARTICLES
Koçyiğit, B. F., & Zhaksylyk, A. (2023) · Central Asian Journal of Medical Hypotheses and Ethics · doi:10.47316/cajmhe.2023.4.3.04 · Cited by 9 · see citing works
Benaïche, A., Billaut-Laden, I., Randriamihaja, H., & Bertocchio, J. (2025) · Journal of Medical Internet Research · doi:10.2196/65651 · Cited by 8 · see citing works
Smutný, Z., & Sudzina, F. (2025) · International Journal of Human-Computer Interaction · doi:10.1080/10447318.2025.2573037 · Cited by 7 · see citing works
Easwaran, V., Orayj, K. M., Bommireddy, B. R., Mantargi, M. J. S., Mulla, M. A., Thammisetty, D. P., Magham, S. R., Bandaru, V., Pradeepkumar, B., & Goruntla, N. (2025) · Scientific Reports · doi:10.1038/s41598-025-31298-2 · Cited by 4 · see citing works
Qianqian, Y., Wang, S., Liu, Y., Luo, J., Deng, Z., Shao, L., & Jiang, Y. (2025) · BMC Medical Education · doi:10.1186/s12909-025-07394-2 · Cited by 4 · see citing works
Artificial intelligence (AI) usage on advanced pharmacy practice experiences
Kehr, H. A., Selby, C., Nohria, R., Gordon, N., Chiyaka, E. T., Battise, D. M., & Donohoe, K. L. (2025) · Currents in Pharmacy Teaching and Learning · doi:10.1016/j.cptl.2025.102562 · Cited by 3 · see citing works
How Humanity Has Always Feared Change: Are You Afraid of Artificial Intelligence?
Véras, M. M. S. (2025) · Cureus · doi:10.7759/cureus.83602 · Cited by 3 · see citing works
Areas of research focus and trends in the research on the application of AIGC in healthcare
Wang, C., Zhu, Y., Zhang, X., Chen, X., Li, Y., Tan, Y., & Qi, H. (2025) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-00947-7 · Cited by 3 · see citing works
Chinene, B., Mudadi, L.-S., Choto, T. A., Soko, N. D., Gonde, L., Mushosho, E. Y., & Mutandiro, L. C. (2024) · Radiography · doi:10.1016/j.radi.2024.11.004 · Cited by 3 · see citing works
Xhaferi, A. (2024) · International Journal of Multilingual Education · doi:10.22333/ijme.2024.8997 · Cited by 2 · see citing works
Morbitzer, K. A., McLaughlin, J. E., Fuller, K. A., Li, X., Noel, Z. R., Rodgers, P. T., Ruby, C. M., Stepanovic, M., & Kane‐Gill, S. L. (2026) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.70257 · Cited by 3 · see citing works
Implications of using conversational robots (chatbots) in uro-oncology
NIEVA-POSSO, D. A., Nieva‐Posso, D. A., & García‐Perdomo, H. A. (2024) · Canadian Urological Association Journal · doi:10.5489/cuaj.8762 · Cited by 2 · see citing works
Saranza, C., Villamar, E. M., Arlan, E. N., Francia, J., Lopio-Alas, L., & Buca, R. (2024) · International Journal of Social Science and Human Research · doi:10.47191/ijsshr/v7-i12-77 · Cited by 2 · see citing works
Urooj, S., & Faheem, M. (2026) · Hospital Pharmacy · doi:10.1177/00185787251405374 · Cited by 1 · see citing works
Wei, J., Dang, D. K., Yang, K., Stokes, E., Mazeh, A. C., Lim, A. S., Dai, D. W., Moore, J. D., Fan, Y., Gašević, D., et al. (2026) · International Conference on Learning Analytics and Knowledge (LAK) · doi:10.1145/3785022.3785059 · Cited by 1 · see citing works
Jia, Z., Dai, D. W., Aryadoust, V., & Hua, Z. (2026) · Research Synthesis in Applied Linguistics · doi:10.1080/29984475.2026.2694603 · Cited by 1 · see citing works
Zhang, T., Le, M.-H., Zlotnik, N., Yee, A. V., Patodia, A., & Austin, Z. (2026) · Pharmacy · doi:10.3390/pharmacy14050113 · Cited by 1 · see citing works
Artificial intelligence and job design: Insights from Job Demands–Resources theory
Bakker, A. B., Junker, T. L., Scharp, Y. S., & Černe, M. (2026) · Technology in Society · doi:10.1016/j.techsoc.2026.103533 · Cited by 1 · see citing works
Diagnostic accuracy and citation integrity of four large language models on otolaryngology vignettes
Pennington-FitzGerald, W., Warrier, A., Durant, S., Sharaf, I., Carlino, F., Pamula, S. D., Eloy, J. A., & Levi, J. (2026) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-026-10253-5
Nogué, S., Amigó‐Tadín, M., & Ríos, J. (2024) · Revista Española de Urgencias y Emergencias · doi:10.55633/s3me/reue.a005.2024
Students' Perception of Using ChatGPT as an AI-Integrated Tool in the Malay Language
Yaqin, L. N., Yusof, B., Yusof, N., & Damit, A. R. (2025) · Jurnal Penelitian dan Pengkajian Ilmu Pendidikan e-Saintika · doi:10.36312/e-saintika.v9i1.2584
Alabsi, H. Z., Almotairi, M., Alyami, M. A., Alqahtani, Y., Obeidat, R., & Almansour, F. (2025) · Advances in intelligent systems and computing · doi:10.1007/978-3-031-89063-5_40
Khababa, G., Khababa, A., Harun, N. H., & Amrani, S. (2025) · International Conference on Emerging Smart Technologies and Applications (eSmarTA) · doi:10.1109/esmarta66764.2025.11132265
Luo, W., Feng, T., Zhang, T., Chen, X., Lu, X., Li, Y., Hou, C., & Gao, J. (2026) · Public Health · doi:10.1016/j.puhe.2026.106252
Thi, T. N., Hai, G. H., Hoang, L. N., & Minh, D. H. (2026) · BMC Medical Education · doi:10.1186/s12909-026-09368-4
Wang, J., Wang, L., Zhang, M., Dong, J., & Xiong, J. (2026) · Education and Information Technologies · doi:10.1007/s10639-026-14044-7
Marót, J. L., Palcsó, T., & Szabó, Z. P. (2026) · Frontiers in Psychology · doi:10.3389/fpsyg.2026.1924487
Aboulqassim, N. S. S., shennib, A. K., alkremy, M. S., fathallah, L., alhamar, E. M., & almajry, M. A. (2026) · Derna Academy Journal for Applied Sciences · doi:10.71147/bgkxz309
Generative AI for Healthcare and Education
Sartori, L., & Piva, R. (2026) · Springer eBooks · doi:10.1007/978-3-031-61050-9_41-1
Lockwood, A., Nisha, S. I., Hendricks, A. E., & Meadan, H. (2026) · Language Speech and Hearing Services in Schools · doi:10.1044/2026_lshss-25-00227
- Authors
- Zawiah, M., Al-Ashwal, F., Gharaibeh, L., Abu Farha, R., Alzoubi, K., Abu Hammour, K., Qasim, Q. A., & Abrah, F.
- Affiliations
- Northern Border University (SA)
- Al-Ayen Iraqi University (IQ)
- Al-Ahliyya Amman University (JO)
- Jordan University of Science and Technology (JO)
- Universiti Sains Malaysia (MY)
- Corresponding author
- Zawiah, Mohammed
- Venue
- Journal of Multidisciplinary Healthcare
- Publisher
- Informa UK Limited
- Published
- 2023-12
- Volume
- Volume 16
- Pages
- 4099-4110
- ISSN
- 1178-2390 (ISSN-L)
- PMC
- PMC10729768
- OpenAlex
- W4389795250
- Semantic Scholar
- 373e695c19f4ea775935ed400bb59b0076114658
- Cited by
- 51
- References
- 31
- Citations by year
- 2026: 15 · 2025: 22 · 2024: 13 · 2023: 1
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Multidisciplinary Healthcare (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- Northern Border University
- Topics
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Physical Sciences › Computer Science › Information Systems › Artificial Intelligence in Education
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Innovations in Medical Education
- Keywords
- ChatGPT, large language models, clinical pharmacy education, PharmD students, student perceptions, overreliance on AI, trust in AI, ethical considerations, care planning, human-AI collaboration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review